Novel lytic bacteriophage AhFM11 as an effective therapy against hypervirulent Aeromonas hydrophila.

MLA

Muliya Sankappa, Nithin, et al. “Novel Lytic Bacteriophage AhFM11 as an Effective Therapy against Hypervirulent Aeromonas Hydrophila.” Scientific Reports, vol. 14, no. 1, July 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1038/s41598-024-67768-2.

APA

Muliya Sankappa, N., Shivani Kallappa, G., Kallihosuru Boregowda, K., Mandrira Ramakrishna, N., Kattapuni Suresh, P., Shriraje Balakrishna, D., Ballamoole, K. K., Thangavel, S., Sahoo, L., Lange, M. D., Deshotel, M. B., & Abernathy, J. W. (2024). Novel lytic bacteriophage AhFM11 as an effective therapy against hypervirulent Aeromonas hydrophila. Scientific Reports, 14(1), 1–14. https://doi.org/10.1038/s41598-024-67768-2

Chicago

Muliya Sankappa, Nithin, Girisha Shivani Kallappa, Kushala Kallihosuru Boregowda, Namrutha Mandrira Ramakrishna, Prithvisagar Kattapuni Suresh, Dheeraj Shriraje Balakrishna, Krishna Kumar Ballamoole, et al. 2024. “Novel Lytic Bacteriophage AhFM11 as an Effective Therapy against Hypervirulent Aeromonas Hydrophila.” Scientific Reports 14 (1): 1–14. doi:10.1038/s41598-024-67768-2.